Variation and effect of the expression of platelet CD40 ligand in patients with premature coronary heart disease

Bin LI,Cheng-zhi LU,Da-sheng XIA,Jian ZHAO,Feng ZHANG,Chao LI

DOI: https://doi.org/10.3969/j.issn.1002-266X.2014.43.005

2014-01-01

Abstract:Objective To explore variation and effect of the expression of CD 40 ligand(CD40L) on platelets in prema-ture coronary heart disease patients .Methods Selected 200 patients experienced coronary artery angiography due to chest congestion or pain as experimental subjects , which were divided as premature coronary heart disease group ( 140 cases of coronary artery stenosis shown on imaging ) and control group ( 60 cases without stenosis ) .Flow cytometry was used for measurement of mean fluorescence intensity about CD 40 L on platelets.Tissue factor (TF) and tissue factor pathway inhibi-tor ( TFPI) were detected by method of ELISA .Results In premature coronary heart disease group , the data of fluores-cence intensity[(19.3 ±6.1) a.u],TF in plasma[(70.0 ±9.5) ng/L],TFPI[(68.0 ±9.4)μg/L], TF/TFPI(1.3 ± 0.1) were collected.Furthermore, the figures were detected as(8.8 ±2.4) a.u,(55.3 ±7.5)ng/L,(59.3 ±7.7)μg/L, (0.9 ±0.1 ) in control group correspondingly .There was significant difference between two groups ( P<0.05 or P <0.01).It had revealed positive correlation between fluorescence intensity of CD 40L on platelets and TF in plasma, TFPI, TF/TFPI of premature coronary heart disease patients (r were 0.43, 0.32, 0.30;all P<0.01).In addition, fluorescence intensity of CD40L on platelets was independenty positive correlated with TF level in plasma (B=0.4, P<0.01) and onset (B=0.8, P<0.01) of premature coronary heart disease.Conclusions The expression of platelet CD40L shows an in-creasing trend in premature coronary heart disease patients .Besides, high level of CD40 L may accelerate the occurrence and development of premature coronary heart disease by stimulating the expression of TF .